Thursday, May 23, 2024
- Advertisement -spot_img

TAG

All News And Stock Ideas

Nvidia Stock Near Buy Point Ahead Of AI Chip Giant’s Earnings Report

Nvidia (NVDA) stock is near a buy point ahead of the AI chipmaker's fiscal first-quarter earnings report, due after the market close Wednesday. X Nvidia stock...

Nvidia Customer Hits Pause, Lam Stock To Split. AI PCs To Drive Chip Sales.

Nvidia (NVDA) stock wavered Tuesday on a report that major customer Amazon.com (AMZN) has halted orders of Nvidia's current data center processors to wait...

Cryptocurrency Prices And News: Ethereum Spikes On ETF Approval Chatter

X Cryptocurrency News: Cryptocurrency prices leapt Monday after Bloomberg increased its odds that the Securities and Exchange Commission will approve spot ethereum ETFs. Elsewhere, bitcoin spiked...

Rivian Lost $38,000 Per Vehicle Delivered In Q1. Is Rivian Stock A Buy Or A Sell?

Rivian Automotive (RIVN) is looking to challenge Tesla (TSLA), Ford (F) and General Motors (GM) with its adventure-styled electric vehicles. RIVN shares surged 40%...

Is Amazon Stock A Buy Amid Leadership Change At AWS Cloud Business?

Amazon.com (AMZN) has started strong in 2024, returning to record share value after a downbeat 2022 that put shares in recovery mode during 2023....

Who Needs Nvidia? Top Funds Madly In Love With This Non-AI Stock.

The latest list of new buys by the best mutual funds had a conspicuous absence we haven't seen this year. Including Nvidia (NVDA), Microsoft...

Cisco Offers Peek Into Fiscal 2025 Revenue, Profit Growth

Cisco Systems (CSCO) reported fiscal third-quarter earnings and revenue that fell from a year earlier but topped consensus estimates as product orders improved from...

Bulls, Bears Clash Over Google, OpenAI Search Advances

Alphabet's (GOOGL) Google will roll out "AI Overview" as part of internet search results across the U.S. starting this week as it battles startup...

Moderna Stock Rebounds From Its RSV Fallout — Is It A Buy, Again?

Moderna (MRNA) stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV vaccine by roughly two weeks. X The news...

Latest news

- Advertisement -spot_img